vs

Side-by-side financial comparison of Lakeshore Acquisition III Corp. (LCCC) and Lucid Diagnostics Inc. (LUCD). Click either name above to swap in a different company.

Lucid Diagnostics Inc. is the larger business by last-quarter revenue ($1.2M vs $717.3K, roughly 1.7× Lakeshore Acquisition III Corp.). Lakeshore Acquisition III Corp. runs the higher net margin — 67.9% vs -858.5%, a 926.4% gap on every dollar of revenue.

Lucid Diagnostics Inc. is a commercial-stage medical diagnostics firm focused on non-invasive screening tests for upper gastrointestinal diseases, including early detection of esophageal cancer and pre-cancerous lesions. It mainly serves healthcare providers and clinical partners across the United States, targeting at-risk patient populations.

LCCC vs LUCD — Head-to-Head

Bigger by revenue
LUCD
LUCD
1.7× larger
LUCD
$1.2M
$717.3K
LCCC
Higher net margin
LCCC
LCCC
926.4% more per $
LCCC
67.9%
-858.5%
LUCD

Income Statement — Q3 FY2025 vs Q3 FY2025

Metric
LCCC
LCCC
LUCD
LUCD
Revenue
$717.3K
$1.2M
Net Profit
$486.8K
$-10.4M
Gross Margin
Operating Margin
-32.1%
-971.0%
Net Margin
67.9%
-858.5%
Revenue YoY
3.3%
Net Profit YoY
16.0%
EPS (diluted)
$0.08
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LCCC
LCCC
LUCD
LUCD
Q3 25
$717.3K
$1.2M
Q2 25
$467.3K
$1.2M
Q1 25
$828.0K
Q4 24
$1.2M
Q3 24
$1.2M
Q2 24
$976.0K
Q1 24
$1.0M
Q4 23
$1.0M
Net Profit
LCCC
LCCC
LUCD
LUCD
Q3 25
$486.8K
$-10.4M
Q2 25
$216.5K
$-4.4M
Q1 25
$-26.9M
Q4 24
$-11.5M
Q3 24
$-12.4M
Q2 24
$-11.0M
Q1 24
$-10.6M
Q4 23
$-10.8M
Operating Margin
LCCC
LCCC
LUCD
LUCD
Q3 25
-32.1%
-971.0%
Q2 25
-53.7%
-978.8%
Q1 25
-1508.1%
Q4 24
-1033.8%
Q3 24
-997.8%
Q2 24
-1146.7%
Q1 24
-1078.1%
Q4 23
-1101.3%
Net Margin
LCCC
LCCC
LUCD
LUCD
Q3 25
67.9%
-858.5%
Q2 25
46.3%
-381.7%
Q1 25
-3249.8%
Q4 24
-964.2%
Q3 24
-1055.5%
Q2 24
-1127.6%
Q1 24
-1060.1%
Q4 23
-1041.3%
EPS (diluted)
LCCC
LCCC
LUCD
LUCD
Q3 25
$0.08
$-0.10
Q2 25
$0.06
$-0.08
Q1 25
$-0.52
Q4 24
$-0.17
Q3 24
$-0.25
Q2 24
$-0.23
Q1 24
$-0.40
Q4 23
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LCCC
LCCC
LUCD
LUCD
Cash + ST InvestmentsLiquidity on hand
$47.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-1.6M
$25.8M
Total Assets
$71.0M
$53.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LCCC
LCCC
LUCD
LUCD
Q3 25
$47.3M
Q2 25
$31.1M
Q1 25
$25.2M
Q4 24
$22.4M
Q3 24
$14.5M
Q2 24
$24.9M
Q1 24
$24.8M
Q4 23
$18.9M
Stockholders' Equity
LCCC
LCCC
LUCD
LUCD
Q3 25
$-1.6M
$25.8M
Q2 25
$-1.4M
$7.9M
Q1 25
$-5.4M
Q4 24
$5.4M
Q3 24
$6.3M
Q2 24
$16.0M
Q1 24
$11.9M
Q4 23
$-2.3M
Total Assets
LCCC
LCCC
LUCD
LUCD
Q3 25
$71.0M
$53.2M
Q2 25
$70.5M
$38.7M
Q1 25
$32.8M
Q4 24
$30.7M
Q3 24
$22.6M
Q2 24
$34.1M
Q1 24
$32.0M
Q4 23
$27.3M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LCCC
LCCC
LUCD
LUCD
Operating Cash FlowLast quarter
$-206.3K
$-10.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
-0.42×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LCCC
LCCC
LUCD
LUCD
Q3 25
$-206.3K
$-10.9M
Q2 25
$-218.3K
$-10.5M
Q1 25
$-12.5M
Q4 24
$-9.9M
Q3 24
$-10.2M
Q2 24
$-11.5M
Q1 24
$-12.6M
Q4 23
$-10.0M
Cash Conversion
LCCC
LCCC
LUCD
LUCD
Q3 25
-0.42×
Q2 25
-1.01×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons